首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 62 毫秒
1.
目的 比较糖尿病病人非体外循环和经典体外循环冠状动脉旁路移植(OPCAB和CCABG)的术后早期临床结果.方法 1999年4月至2008年1月,318例糖尿病病人行冠状动脉旁路移植术(CABG).OPCAB 210例,CCABG 108例.两组术前总体情况差异无统计学意义.OPCAB在非体外循环、心脏跳动下完成,CCABG在体外循环、心脏停跳下完成.正中开胸,胸膜外游离带蒂左乳内动脉(LIMA),与左前降支(LAD)吻合,大隐静脉(GSV)与其他靶血管吻合,吻合口超过2个采用序贯吻合.术前口服降糖药或皮下注射胰岛素将血糖控制在6 mmol/L以下,术后早期在ICU时持续泵入胰岛素,将血糖控制在6~8mmol/L.结果 两组共5例(1.57%)死亡,7例(2.20%)发生并发症.两组均达到完全再血管化,平均移植旁路血管OPCAB组(2.6±1.1)支,低于CCABG组的(3.1±1.3)支,P<0.05.OWCAB组死亡1例(0.48%),明显低于CCABG组4例(3.70%),P<0.05.OPCAB组发生并发症5例(2.30%),CCABG组2例(1.85%),组间差异无统计学意义,P>0.05.结论 糖尿病者冠状动脉旁路移植手术围术期严格控制血糖至接近正常水平,住院病死率和并发症率低.OWAB术后早期病死率明显低于CCABG.  相似文献   

2.
目的通过观察非体外循环冠状动脉旁路移植术(OPCAB)与常规冠状动脉旁路移植术(CCABG)患者术后心肌肌钙蛋白I(cTnI)和肌酸激酶同工酶(CK-MB)的动态变化,比较两种手术方式对心肌的损伤情况.方法102例不稳定型心绞痛患者,按不同的手术方式分为OPCAB组和CCABG组.OPCAB组:71例,行OPCAB;CCABG组:31例,行CCABG.两组分别于术前、术后4、12小时、1、3、5天测定cTnI和CK-MB.结果CCABG组行旁路血管移植2~5支(2.97±0.84支),OPCAB组1~5支(2.69±0.92支);两组均无围术期心肌梗死.两组术后早期cTnI和CK-MB均有升高,分别于术后5天和术后3天基本恢复至术前水平.术后4、12小时、术后1天OPCAB组cTnI值与CCABG组比较差别有显著性意义(P<0.01).结论有选择的施行OPCAB是一种安全和合理的手术方式,OPCAB的心肌损伤程度明显轻于CCABG.  相似文献   

3.
目的 评价非体外循环下冠状动脉旁路移植术 (OPCAB)与常规体外循环下冠状动脉旁路移植术(CCABG)相比是否具有优越性。 方法 将 170例 2支以上血管病变行冠状动脉旁路移植术 (不包括瓣膜手术或室壁瘤切除等合并手术的病例 )患者分为 OPCAB组和 CCABG组 ,OPCAB组通过胸骨正中切口 ,在非体外循环心脏不停跳下完成冠状动脉旁路移植术 ;CCABG组建立常规体外循环 ,心脏停搏下完成冠状动脉旁路移植术。对两组病例的术前和术后各项指标进行对比分析。 结果 两组患者术前的一般情况无差异 ,OPCAB组与 CCABG组间曾行溶栓或经皮腔内冠状动脉成形术治疗和 3支病变的比例分别为 31.8%比 18.3%和 5 9%比 78% ,移植旁路血管分别为3.6± 0 .8支比 4.3± 1.0支 (P<0 .0 1) ,但所用的血管材料两组间无差异。OPCAB组术后呼吸机辅助时间和外科住院时间较短 ,住院费用较低 (P<0 .0 5 )。但术后并发症如二次开胸止血、伤口感染、心律失常、围术期心肌梗死、肺部并发症等的发生率 OPCAB组为 9.8% ,CCABG组为 14.6 % ;OPCAB组无手术死亡 ,CCABG组死亡 1例 (P>0 .0 5 )。 结论  OPCAB治疗冠心病多支病变的初期结果显示可以减少患者术后辅助呼吸时间和外科住院时间 ,降低住院费用。但目前尚不能替代 CCABG,其近、远期效果仍  相似文献   

4.
Gao CQ  Zhang T  Li BJ  Xiao CS  Wu Y  Ma XH  Liu GP 《中华外科杂志》2005,43(22):1429-1432
目的比较非体外循环和体外循环下冠状动脉旁路移植术(CABG)的左乳内动脉(LIMA)和大隐静脉(SV)桥血流的变化。方法将547例行CABG患者分为非体外循(OPCAB)组(403例)和体外循环(CCABG)组(144例)。常规用LIMA与左前降支(LAD)吻合,其余靶血管使用SV吻合。于全部吻合口吻合完毕血流动力学稳定情况下,用即时血流测量仪(TTFM)直接测量并记录桥血流各项参数。结果搏动指数(PI值)、无效血流率及舒张期峰流量,LIMA桥OPCAB组分别为2.7±1.8,(2.2±4.3)%,(46.8±2.7)m l/m in,CCABG组分别为2.8±2.0,(3.4±3.1)%,(52.8±3.7)m l/m in;SV桥,OPCAB组分别为2.8±0.1,(1.8±0.3)%,(85.8±3.2)m l/m in,CCABG组分别为2.6±0.2,(1.3±0.2)%,(93.9±5.6)m l/m in,两组比较差异均无统计学意义(P均>0.05);平均流量及收缩期峰流量,CCABG组[SV桥(62.9±3.9)与(106.9±7.3)m l/m in,LIMA桥(32.5±23.5)与(41.6±4.4)m l/m in]均大于OPCAB组[SV桥(47.2±1.7)与(58.0±2.7)m l/m in,LIMA桥(26.5±19.9)与(27.0±1.6)m l/m in],差异有统计学意义(t=6.61,6.77,5.16,5.96,P均<0.01);CCABG组血管阻力LIMA桥与SV桥分别为(3.6±0.3)与(1.6±0.2)mm Hg.m l-1.m in-1,小于OPCAB组的(4.7±0.2)与(2.7±0.1)mm Hg.m l-1.m in-1,两者比较差异有统计学意义(t=4.32,P均<0.01)。结论CCABG组与OPCAB组对比,桥血管的通畅率无显著性差别。  相似文献   

5.
目的 评价非体外循环下冠状动脉旁路移植术 (OPCAB)与体外循环下冠状动脉旁路移植术 (CCABG)治疗冠状动脉三支病变术中旁路早期通畅性。方法  6 0例 3支血管病变的病人分为OPCAB组和CCABG组 ,每组各 30例。行冠状动脉旁路移植术 ,OPCAB组胸骨正中切口 ,在非体外循环心脏不停跳下完成手术 ;CCABG组建立常规体外循环 ,心脏停跳下完成手术。术中应用即时血流测量技术对旁路血管进行流量测量。对比分析两组术前、术后的各项指标及各血管旁路流量、搏动指数和血流波形。结果 两组病人术前一般情况差异无统计学意义。OPCAB组与CCABG组移植旁路血管分别为 (3 6±0 6 )支与 (4 3± 0 9)支 (P <0 0 1) ;两组前降支及右冠状动脉旁路血流量、搏动指数差异无显著性。CCABG组回旋支序贯旁路和远端吻合口多 ,血流量较OPCAB组高。两组弥漫病变血管旁路血流量小。结论 OPCAB与CCABG治疗 3支病变 ,两组血管旁路早期通畅性差异无显著性。  相似文献   

6.
再次冠状动脉旁路移植术的临床应用   总被引:1,自引:0,他引:1  
目的总结再次冠状动脉旁路移植术(CABG)治疗冠心病的临床经验和手术效果。方法2001年6月~2006年12月,对18例冠心病患者行再次CABG。术前心绞痛(CCS分级)级7例,级11例;冠状动脉造影显示:16例均有原移植静脉狭窄/闭塞,2例左乳内动脉(LIMA)-左前降支(LAD)桥狭窄/闭塞,6例自体冠状动脉出现新的病变。全组均经原胸骨正中切口径路手术,常规体外循环(CPB)下CABG15例,非体外循环冠状动脉旁路移植术(OPCAB)3例;同期行室壁瘤切除、左心室成形1例,二尖瓣成形术3例,主动脉瓣和二尖瓣双瓣膜置换联合右颈动脉内膜剥脱术1例。应用LIMA12例次、双侧IMA4例次、桡动脉3例次,其余为大隐静脉或小隐静脉。结果15例常规CABG患者主动脉阻断时间45~112min(57±26min),CPB时间66~140min(78±24min)。再次CABG每例移植血管1~5支,平均每例远端吻合口3.11个。手术结束用血流仪测定移植血管血流量均满意(血流量27.0±12.5ml/min),搏动指数均<4.2。手术后因低心排血量需主动脉内球囊反搏辅助1例,术后6d发生肾功能衰竭死亡。其余17例患者术后呼吸机辅助呼吸时间5~15h,心绞痛均消失,围手术期无心肌梗死发生,胸腔引流量为290~1040ml,顺利恢复,均出院。术后随访17例,随访时间6.0个月~4.5年,均无心绞痛发作,4例复查冠状动脉造影,显示移植血管均通畅。结论再次CABG难度大于首次CABG,但只要手术中能正确找到靶血管,移植血管的血流可靠、完全再血管化和有良好的围术期管理,再次CABG可达到与首次手术同样的效果。  相似文献   

7.
国人桥血流搏动指数的研究   总被引:8,自引:0,他引:8  
目的 研究冠状动脉旁路移植术 (CABG)国人桥血流的搏动指数 (PI值 )合适的范围。方法 将 35 7例CABG病人分为二组 ,不停跳 (OPCAB)组 2 6 3例 ,停跳 (CCABG)组 94例。常规用原位带蒂左乳内动脉 (LIMA)与左前降支 (LAD)吻合 (LIMA组 ) ,其余桥使用大隐静脉 (SV组 )。SV吻合口多于 2个时采用序贯式吻合 ,近端吻合于升主动脉。移植完毕动脉血压稳定后 ,用直径为 2~ 3mm超声微探头直接测量LIMA和SV桥的平均血流量、收缩期和舒张期血流量以及PI值 ,并记录血流波形。确定PI值“合适”的标准 :舒张期血流波形良好 ;平均血流量大于 10ml min ;术中及术后CK MB、cTnI在正常范围和无ECG改变及手术后临床症状改善等。结果 各组测量桥血流时血压差异无显著性。共测量LIMA 35 7根 ,SV 32 4根。LIMA之PI值 :OPCAB为 2 4 9± 0 91,CCABG为 2 39± 1 16 ;SV之PI值 :OPCAB为 2 6 8±1 35 ,CCABG为 2 5 9± 1 4 2 ;各组间PI值差异无显著性 (P >0 0 5 )。用全部PI值计算出总体平均值为2 5 6± 2 35 (95 %置信度 )。结论 国人冠状动脉旁路移植术桥血流的PI的参考值范围为小于 5。  相似文献   

8.
目的 探讨非体外循环冠状动脉旁路移植术(OPCAB)治疗冠状动脉慢性完全闭塞病变(CTO)的可行性,总结其临床经验. 方法 1999年8月~2007年10月我院共收治696例CTO患者,共853支冠状动脉完全闭塞(其中冠状动脉造影显示显示无逆显影127支、有逆显影726支),均行OPCAB(术前冠状动脉造影显示无逆显影的CTO患者中术中有26支有血流,而有逆显影的CTO患者中有63支无血流),共移植血管桥2 231支.其中施行内膜剥脱术(CE)后行冠状动脉旁路移植术(CABG)136支,行心中静脉原位静脉动脉化28支.术中有15例因血流动力学不稳定改为体外循环下CABG,其中6例安放主动脉内球囊反搏(IABP). 结果术中无死亡患者;术后住院期间死亡6例,其中2例死于严重低心排血量,2例死于肾功能衰竭,1例死于围术期心肌梗死,1例死于脑血管意外.术后发生应激性溃疡1例,纵隔感染1例,均经对症治疗后痊愈.术后随访1个月~9年,随访686例(99.42%),失访4例;心绞痛缓解率99.85%(685/686),心功能分级(NYHA)Ⅰ~Ⅱ级. 结论 CTO患者应用OPCAB可以取得良好的治疗效果,手术死亡率及并发症明显降低.冠状动脉造影对评价冠状动脉完全闭塞有一定的局限性,冠状动脉血管内视镜技术和血管内超声心动图可以协助诊断.  相似文献   

9.
非体外循环下冠状动脉旁路移植术   总被引:12,自引:3,他引:9  
目的 探讨和评价微创非体外循环冠状动脉旁路移植术 (OPCAB)的临床效果。 方法  38例 OPCAB患者中左冠状动脉主干病变 4例 ,1支血管病变 10例 ,2支 14例 ,3支 10例 ,均经胸骨正中切口行 OPCAB,每例移植血管 1~ 5支 ,平均移植血管 2 .42支。应用左乳内动脉 38支 ,大隐静脉 5 4支。 结果 全组无手术死亡 ,36例顺利完成手术 ,2例转为心肺转流术下冠状动脉旁路移植术。38例均在手术后 2~ 12小时 ,平均 4.9± 2 .6小时顺利拔除气管内插管。全组均顺利康复 ,15例手术后 1个月内恢复了原工作。 结论 对有适应证的患者 ,OPCAB是一项安全有效的术式  相似文献   

10.
合并慢性肾功能不全患者的冠状动脉旁路移植术   总被引:4,自引:3,他引:1  
目的 探讨冠状动脉粥样硬化性心脏病 (冠心病 )合并慢性肾功能不全患者行冠状动脉旁路移植术(CABG)时手术方式的选择。 方法  15例冠心病合并慢性肾功能不全患者根据施行的术式不同分为两组 ,常规CABG(CCABG)组 :9例患者 ,在体外循环下行 CCABG。OPCAB组 :6例患者 ,行非体外循环冠状动脉旁路移植术(OPCAB)。术后观察两组肾功能情况、心律失常、呼吸和神经系统并发症、移植血管支数、呼吸机辅助时间、术后出血量和输血量等临床指标。 结果 全组无手术死亡 ,CCABG组患者术后早期肾功能较术前差 (P<0 .0 5 ) ;OPCAB组患者术后早期肾功能较术前无明显变化 (P>0 .0 5 ) ,术后并发症比 CCABG组低 ,手术时间、ICU时间和术后呼吸机辅助时间均比 CCABG组短 ,术后出血量和输血量比 CCABG组少 (P<0 .0 5 )。 结论 冠心病术前合并肾功能不全的患者 ,采用 OPCAB术式明显优于 CCABG,经围术期的积极处理 ,大多数患者可渡过肾功能衰竭关。  相似文献   

11.
Using a regional cardiopulmonary bypass (CPB) registry, we compared the practice of CPB at eight northern New England institutions to recently published recommendations. We examined CPB practice among 3597 adult patients undergoing isolated coronary artery bypass grafting surgery from January 2004 to June 2005. Registry variables were used to compare regional CPB practice to recommendations on topics of neurologic protection (pH management, avoidance of hyperthermia, minimizing return of pericardial suction blood, aortic assessment, arterial line filtration), maintenance of euglycemia, reduction of hemodilution, and attenuation of the inflammatory response. We report overall regional practice (regional minimum, maximum). All centers used alpha-stat pH management and arterial line filters. Avoidance of hyperthermia (temperature < 37degrees C) was achieved during 23.4% of procedures (regional minimum, 1.5%; maximum, 83.2%). Minimizing return of pericardial suction blood was achieved in 23.7% of cases (0.7%, 93.6%). Aortic assessment was performed during 45.7% of procedures (1.3%, 98.9%). Maintenance of euglycemia (< 200 mg/dL) was accomplished in 82.7% (57.1%, 97.9%) of cases. Hemodilution (hematocrit < 23% on CPB) was lower for men 32.4% (20.6%, 52.3%) than women 77.9% (64.7% 88.9%). Men were less likely to receive red blood cell transfusions in the operating room (11.0%; 1.8%, 20.9%) than women (54.6%; 30.1%, 70.6%). In an effort to attenuate the inflammatory response, surface coated circuits were used in 83.3% of procedures (8.8%, 100%). During this time, gaps existed between regional CPB practice and recently published recommendations. We continue to prospectively measure CPB practice relating to these recommendations to monitor and improve the care provided to our patients.  相似文献   

12.
Long-term evaluation of EC-IC bypass patency   总被引:2,自引:0,他引:2  
Summary The EC-IC Bypass Study Group could not detect any benefit from surgery compared to medical management in the prevention of stroke in 1985 [15]. During the past years surgical revascularization was re-evaluated and considered as an appropriate treatment for a small subgroup of patients with recurrent focal cerebral ischaemia and impaired haemodynamics. This retrospective study examines the long-term benefit and patency rate of bypass.We present a follow-up of 5.6 years of 47 patients, all of whom underwent byupass surgery after 1985. Forty patients suffered recurring transient ischaemic attacks due to uni- or bilateral internal carotid artery occlusion. Examination included neurologic status, TCD with CO2 or Diamox challenge, angiography, CT and SPECT scans.Neurological improvement was seen in 23% of patients with better results after early surgery, a worsening in 22% suffering further ischaemic events on a postoperative average of 2.8 years. Patency rate for vein graft material was 50%, for the STA-MCA procedure 91%. Occlusion of the vein graft occurred on an average after 1.4 years, other anastomosis after 2.7 years.We conclude that only few patients derived long-term benefit from EC-IC bypasses. Functioning of the bypass worsens over time, suggesting a role for surgery predominantly in the first year of ischaemic events due to insufficient collateral supply. Actual indications for bypass surgery may be patients with failure of maximal medical therapy and progressive ischaemia and haemodynamic compromise.  相似文献   

13.
Marginal ulcers are a recognized complication of gastric bypass procedures for obesity. Perforated marginal ulcer (PMU) is a life-threatening complication of marginal ulcers. We performed a systematic review to understand the presentation, management, and outcomes of PMUs. PubMed, Google Scholar, and Embase databases were searched to identify all studies on PMUs after gastric bypass procedures. A total of 610 patients were identified from 26 articles. The mean age was 39.8±2.59 years, and females represented most of the cohort (67%). The mean body mass index was 43.2±5.67 kg/m2. Most of the patients had undergone a Roux-en-Y gastric bypass (98%). The time gap between the primary bariatric surgery and the diagnosis of PMU was 27.5±8.56 months. The most common presenting symptom was abdominal pain (99.5%) and a computed tomography scan was the diagnostic modality used in 72% of the patients. Only 15% of patients were on prophylactic proton pump inhibitors or H2 blockers at the time of perforation, and 41% of patients were smoking at the time. Twenty-three percent of patients were on nonsteroidal anti-inflammatory drugs. Laparoscopic omental patch repair of the perforation (59%) was the most used technique; 18% of patients underwent open surgery, and 20% were managed non-surgically. Thirty-day mortality was 0.97%; it was 1.21% (n=5) and 0% (n=0) in those who were managed surgically and nonsurgically, respectively. Ulcers recurred in 5% of patients. In conclusion, PMU is a surgical emergency after gastric bypass that can result in significant morbidity and even mortality. This is the first systematic review in scientific literature characterizing this condition.  相似文献   

14.
Objective: The purpose of this study is to compare the operative results of off-pump coronary artery bypass (OPCAB) and on-pump (conventional) coronary artery bypass (CCAB), to clarify qualitative problems and whether OPCAB is less invasive or not. Methods: OPCAB was consecutively performed in 63 patients and CCAB in 63 patients between July 1998 and December 2003. Results: The mean number of bypass grafts was 2.43 ±0.82 in the OPCAB group and 2.70±0.71 in the CCAB group (p=0.096). In-hospital mortality was 0% in the OPCAB group and 3.2% in the CCAB group. The incidence of perioperative myocardial infarction was 0% in the OPCAB group and 3.2% in the CCAB group. The incidence of postoperative major complications was significantly lower in the OPCAB group than in the CCAB group (OPCAB group=4 complications, CCAB group=13 complications). Cerebrovascular accidents occurred in 1.6% of patients in both groups. The incidence of sternal infection or mediastinitis was 0% in the OPCAB group and 3.2% in the CCAB group. The early patency rate of graft was 94.0% in the OPCAB group and 92.8% in the CCAB group, and was not significantly different (p=0.822). Conclusion: Operative mortality and major complications after surgery in OPCAB were lower than that in CCAB. The early patency rate in OPCAB was as good as that in CCAB. It is considered that OPCAB is less invasive and the quality of bypass in OPCAB is as good as that in CCAB.  相似文献   

15.
Certain patients have atherosclerosis in both aortoillac and femoropopliteal segments of the arterial tree and thus do not have a good result from reconstruction of the aortoiliac segment. No method has been developed to identify these patients and we do not know whether, by combining a femoropopliteal bypass with an aortobifemoral bypass, the results can be improved. We present a series of 153 patients with severe multilevel occlusive disease treated by simultaneous reconstruction and followed for up to 6.5 years. The cumulative patency of the femoropopliteal bypasses was 80% at four years. Functional and symptomatic improvement was excellent, and operative mortality was low when one considers the age and poor general condition of the patients.  相似文献   

16.
This randomized trial compared the patency of direct unilateral aorto- or iliofemoral prosthetic bypass with that of crossover femorofemoral or iliofemoral bypass in unilateral atheromatous occlusive disease of the iliac artery. Between May 1986 and March 1991, 143 patients were enrolled in this study (74 crossover and 69 direct revascularizations). Cardiovascular risk factors, preoperative symptoms, and atheromatous lesions were similar in both groups. Patients were followed by Duplex scanning with systolic pressure index measurements. Routine digital subtraction arteriograms were obtained postoperatively and separately, when hemodynamic anomalies developed. Mean follow-up was 22 months. One patient with direct revascularization died postoperatively. Primary patency of direct revascularizations was 89.8% at 48 months compared with 52% for crossover bypass. This difference was statistically significant. Secondary patency of direct and crossover revascularization at 48 months was 92.9% and 93.6%, respectively (not significant). Even though crossover bypasses seem attractive because of their technical simplicity and low morbidity, our results suggest that direct revascularizations are preferable in the young patient with no major operative risks, while crossover bypasses remain indicated in patients at risk.Presented at the Annual Meeting of the Société de Chirurgie Vasculaire de Langue Française, June 20–21 1991, Marseille, France.  相似文献   

17.
Between May 1, 1983 and May 1, 1985, 53 patients whose mean age was 75 years, and who presented with rest pain or ischemic changes had infrageniculate insertion of femoropopliteal or femorotibial thin-walled polytetrafluoroethylene (PTFE-TW) bypasses. Occlusive atherosclerotic disease was present in all patients. Postoperative follow-up ranged from 6 to 30 months. One patient died in the immediate post-operative period whereas 15 others died later during follow-up. There was one case of prosthetic sepsis. No anastomotic aneurysms occurred. Actuarial analysis of overall patency rates in significant population samples showed that 88% and 68% of bypasses were functional at one month and two years, respectively. The overall rate of early amputation was 17%. Overall limb salvage was 67% at 30 months. In patients over 75, 85% of bypasses were patent at one year whereas life expectancy for one year in this same group of patients was 49%. Although this is a preliminary study, results obtained with this new material suggest that an average gain of 20% in patency rates can be expected compared to those recorded with standard PTFE prostheses. The PTFE-TW vascular prosthesis may be the material of first choice for the geriatric patient in order to promote early hospital discharge and return to the home environment. Even though long-term patency rates of venous grafts are better, we believe that the use of PTFE-TW prostheses in elderly patients with limited life expectancy may be preferred.  相似文献   

18.
Percutaneous cardiopulmonary bypass (PCPB) has recently come to the forefront of medicine as a technique for resuscitating and supporting patients in various clinical situations. Current systems utilize small-diameter cannulas to aspirate blood under high suction into the cardiopulmonary bypass circuit. Aspiration-based systems have several disadvantages including risk of air embolism, blood hemolysis, and cavitation. Additionally, they are suboptimal for use during open-heart surgical procedures. A system with a venous cannula that employs gravity drainage has been evaluated. Once advanced into position over a guide- wire, the stylet is removed, causing the basket near the end of the cannula to expand. Blood flows into the cannula from side holes and the basket region, which prevents the vessel wall or atrium from collapsing around the catheter and impeding venous drainage. Hemodynamic, hematologic, and histologic examinations were performed on eight anesthetized mongrel dogs during 2 h of PCPB. All animals exhibited adequate tissue perfusion and right and left heart decompression. All animals were successfully weaned from PCPB and after 30 min exhibited normal myocardial function. No ischemic changes were observed in the heart, lung, kidney, or liver by light and electron microscopy. We conclude that full PCPB can be satisfactorily achieved by using a novel percutaneous venous cannula and gravity drainage  相似文献   

19.
A pneumatically driven artificial heart with a tubular silicone rubber membrane and disc valves was used for functional heart replacement in the paracorporeal mode. A fluidic drive system allows adjustment of the heart rate, positive and negative pressures and systole/diastole ratio.
Since August, 1977, the artificial heart has been used in four patients with refractory postoperative heart failure not responding to volume loading, pH and electrolyte correction, catecholamines and intraaortic balloon pumping. Large cannulae were placed in the atria and great vessels. The ventricles were fixed on the chest paracorporeally. The assist system was used as a left heart bypass in one patient and as a biventricular bypass in three other patients. After 48–72 hours, the ventricular function recovered in three patients, permitting removal of the artificial heart. One patient died of cerebral complications six weeks later; the other two recovered completely and were released in good condition.
Profound postoperative heart failure can be completely reversed by the use of the paracorporeal artificial heart; the advantage of the system lies in the simplicity of its implantation and removal.  相似文献   

20.
We evaluated the effectiveness of a sequential bypass for multisegmental occlusive disease. Forty-seven multiple bypass grafts were performed on 43 patients ranging in age from 55 to 83 years (mean: 70 years). The indications for operation included incapacitating claudication in 20 limbs, resting pain in 15, and nonhealing ulcers in 12. An anatomical arterial bypass was performed on 36 limbs, consisting of an aorto-femoro-popliteal bypass in 21 limbs, a femoro-popliteal-posterior tibial bypass in 8, an ilio-femoro-popliteal bypass in 4, an ilio-femoro-posterior tibial bypass in 2, and a femoro-popliteal-plantar bypass in 1. Similarly, an extra-anatomical arterial bypass was performed on 11 limbs, consisting of an axillo-femoro-popliteal bypass in 6, a crossover femoro-femoro-popliteal bypass in 3, an axillo-femoro-posterior tibial bypass in 1, and a crossover femoro-femoro-anterior tibial bypass in 1. The follow-up period ranged from 3 to 77 months (mean: 23 months). Twelve graft failures occurred, and 2 of them required major amputations. The cumulative graft patency rate was 85% at one year and 65% at 3 years. Arterial Doppler examination revealed a mean preoperative ankle-brachial index of 0.29±0.25. The early and late mean postoperative ankle-brachial indices, however, increased to 0.97±0.19 and 0.84±0.25, respectively. Midterm results have indicated that such multiple sequential bypass grafts are effective.Presented at the 8th Congress Asian Surgical Association, Fukuoka, Japan, March 10–13, 1991  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号